Use of albumin infusion for cirrhosis-related complications: An international position statement

Bibliographic Information
Authors: Bai Z.; Méndez-Sánchez N.; Romeiro F.G.; Mancuso A.; Philips C.A.; Tacke F.; Basaranoglu M.; Primignani M.; Ibrahim M.; Wong Y.J.; Nery F.G.; Teschke R.; Ferreira C.N.; Muñoz A.E.; Pinyopornpanish K.; Thevenot T.; Singh S.P.; Mohanty A.; Satapathy S.K.; Ridola L.; Maruyama H.; Cholongitas E.; Levi Sandri G.B.; Yang L.; Shalimar; Yang Y.; Villa E.; Krag A.; Wong F.; Jalan R.; O'Brien A.; Bernardi M.; Qi X.
Journal: JHEP Reports
Publisher: Elsevier B.V.
Publication Date: August 2023
Volume / Issue: Volume 5 / Issue 8
Article No.: 100785
ISSN: 25895559
DOI: 10.1016/j.jhepr.2023.100785
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Bai Z., Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, China, Department of Life Sciences and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, China; Méndez-Sánchez N., Liver Research Unit, Medica Sur Clinic and Foundation, National Autonomous University of Mexico, Mexico City, Mexico; Romeiro F.G., Internal Medicine Department, Botucatu Medical School, São Paulo, Brazil; Mancuso A., Medicina Interna 1, Azienda di Rilievo Nazionale ad Alta Specializzazione Civico-Di Cristina-Benfratelli, Palermo, Italy; Philips C.A., Clinical and Translational Hepatology, The Liver Institute, Center of Excellence in GI Sciences, Rajagiri Hospital, Aluva, India; Tacke F., Department of Hepatology and Gastroenterology, Charité Universitätsmedizin Berlin, Berlin, Germany; Basaranoglu M., Division of Gastroenterology, Department of Internal Medicine, Bezmialem Vakif University, Istanbul, Turkey; Primignani M., Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Ibrahim M., Department of Gastroenterology and Hepatology, Theodor Bilharz Research Institute, Cairo, Egypt; Wong Y.J., Department of Gastroenterology and Hepatology, Changi General Hospital, Singapore; Nery F.G., Serviço de Cuidados Intensivos, Unidade de Cuidados Intermédios Médico-Cirúrgica, Centro Hospitalar Universitário do Porto, Porto, Portugal; Teschke R., Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, Germany; Ferreira C.N., Serviço de Gastrenterologia e Hepatologia, Hospital de Santa Maria-Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal; Muñoz A.E., Sección Hepatología, Hospital Dr. Carlos B. Udaondo. Ciudad Autónoma de Buenos Aires, Argentina; Pinyopornpanish K., Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Thevenot T., Centre Hospitalier Universitaire de Besançon, Hôpital Jean Minjoz, Service d'Hépatologie et de Soins Intensifs Digestifs, Besançon, France; Singh S.P., Kalinga Gastroenterology Foundation, Odisha, India; Mohanty A., Section of Gastroenterology, Boston Medical Center, Boston, MA, United States; Satapathy S.K., Department of Internal Medicine, Division of Hepatology, Sandra Atlas Bass Center for Liver Diseases & Transplantation, Donald and Barbara Zucker School of Medicine for Hofstra/Northwell Health, Manhasset, NY, United States; Ridola L., Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, Italy; Maruyama H., Department of Gastroenterology, Juntendo University, Hongo, Tokyo, Bunkyo-ku, Japan; Cholongitas E., First Department of Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Levi Sandri G.B., Division of General Surgery and Liver Transplantation, San Camillo Hospital, Rome, Italy; Yang L., Sichuan University-University of Oxford Huaxi Joint Centre for Gastrointestinal Cancer, Department of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China; Shalimar, Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India; Yang Y., Senior Department of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China; Villa E., Department of Gastroenterology, University of Modena & Reggio Emilia and Azienda Ospedaliero-Universitaria di Modena, Italy; Krag A., Institute of Clinical Research, University of Southern Denmark, Odense, Denmark; Wong F., Department of Medicine, University of Toronto, Toronto, ON, Canada; Jalan R., Liver Failure Group, UCL Institute for Liver and Digestive Health, The Royal Free Hospital, University College London, London, United Kingdom; O'Brien A., Division of Medicine, Royal Free Campus, London, United Kingdom; Bernardi M., Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; Qi X., Department of Gastroenterology, General Hospital of Northern Theater Command, Shenyang, China, Department of Life Sciences and Biopharmaceutics, Shenyang Pharmaceutical University, Shenyang, China
Abstract
Background & Aims: Numerous studies have evaluated the role of human albumin (HA) in managing various liver cirrhosis-related complications. However, their conclusions remain partially controversial, probably because HA was evaluated in different settings, including indications, patient characteristics, and dosage and duration of therapy. Methods: Thirty-three investigators from 19 countries with expertise in the management of liver cirrhosis-related complications were invited to organise an International Special Interest Group. A three-round Delphi consensus process was conducted to complete the international position statement on the use of HA for treatment of liver cirrhosis-related complications. Results: Twelve clinically significant position statements were proposed. Short-term infusion of HA should be recommended for the management of hepatorenal syndrome, large volume paracentesis, and spontaneous bacterial peritonitis in liver cirrhosis. Its effects on the prevention or treatment of other liver cirrhosis-related complications should be further elucidated. Long-term HA administration can be considered in specific settings. Pulmonary oedema should be closely monitored as a potential adverse effect in cirrhotic patients receiving HA infusion. Conclusions: Based on the currently available evidence, the international position statement suggests the potential benefits of HA for the management of multiple liver cirrhosis-related complications and summarises its safety profile. However, its optimal timing and infusion strategy remain to be further elucidated. Impact and implications: Thirty-three investigators from 19 countries proposed 12 position statements on the use of human albumin (HA) infusion in liver cirrhosis-related complications. Based on current evidence, short-term HA infusion should be recommended for the management of HRS, LVP, and SBP; whereas, long-term HA administration can be considered in the setting where budget and logistical issues can be resolved. However, pulmonary oedema should be closely monitored in cirrhotic patients who receive HA infusion. © 2023 The Author(s)
Keywords
Decompensated; Human albumin; Kidney injury; Liver failure; Management; Portal hypertension; Sepsis; bilirubin; creatinine; acute liver failure; anaphylaxis; Article; ascites; bacterial peritonitis; bilirubin blood level; bleeding; chronic liver failure; creatinine blood level; decompensated liver cirrhosis; Delphi study; hepatic encephalopathy; hepatorenal syndrome; human; hyponatremia; kidney failure; liver cirrhosis; lung edema; muscle cramp; paracentesis; septic shock; survival rate
Citation Information
Scopus Citations: 53
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
